I think more like .30 on real good news but $1 would need a merger or FDA approval. In all honesty they are headed in the right direction cleaning house the way they have. But after they show good growth they might need a R/S to get big boys involved. If they product shows more promise buyout could be an option answer.
(0)
(0)
Provectus Biopharmaceuticals Inc. (PVCT) Stock Research Links